Clorox (CLX) In-Depth Stock Report
A full valuation and forecasting workup on Clorox, the household-products company behind brands including Clorox bleach and disinfecting wipes, Pine-Sol, Glad trash bags, Burt's Bees, and Kingsford charcoal, spanning multiple product categories built around cleaning, disinfecting, and everyday household needs. Every number below is computed live from BriMindInvest's own data pipeline, not copied from a template.
Investment Summary
Every headline number this report produces, collected in one place before the analysis that derives them. All figures are computed live at page load, so this block reflects the market as of the moment you opened the page.
- Seven independent intrinsic-value methods run live against current financials, with an implied upside/downside versus the current price.
- A proprietary six-factor AI Score (value, growth, profitability, health, momentum, risk) percentile-ranked against our full coverage universe.
- A blended 1-year price target combining our internal model with live Wall Street analyst consensus.
- A 5-year Monte Carlo simulation built from 2,000 bootstrap paths over Clorox's own historical monthly returns — a probability band, not a single guess.
- A structured bull case, bear case, catalyst list, and risk register written specifically for this report.
- A breakdown of Clorox's Health & Wellness, Household, Lifestyle, and International segments and their differing growth profiles.
- Live analyst rating distribution, institutional ownership breakdown, quarterly EPS beat/miss history, and multi-year revenue and net income — pulled directly from aggregated sell-side and financial-statement data.
Executive Summary
Clorox (NYSE: CLX) is a household-products company best known for its namesake bleach and disinfecting-wipes brand, alongside a broader portfolio including Pine-Sol, Glad trash bags, Burt's Bees personal care, and Kingsford charcoal.
The company organizes its portfolio across Health & Wellness (cleaning and disinfecting products), Household (Glad, Fresh Step, Kingsford), Lifestyle (Burt's Bees, Hidden Valley, Brita), and International segments.
Clorox experienced a significant demand surge during the COVID-19 pandemic for disinfecting products, followed by a normalization period as elevated pandemic-driven demand faded, complicating multi-year growth comparisons.
The company has also navigated a major cybersecurity incident in recent years that disrupted operations and highlighted supply-chain and IT-infrastructure risk considerations relevant to ongoing operational resilience.
This report walks through Clorox's live valuation across seven independent methods, its proprietary AI Score, a blended analyst price target, and a 5-year Monte Carlo simulation — then lays out the bull case, bear case, and the specific catalysts and risks most likely to move the stock, with particular attention to post-pandemic demand normalization and input-cost trends.
Industry & Market Backdrop
The broader competitive and macro environment CLX operates in — context a pure valuation table can't convey on its own.
The household-products industry generally exhibits stable, non-discretionary demand, since cleaning and disinfecting products are recurring purchases largely insulated from economic cycles, though pandemic-era demand spikes created unusual multi-year comparison distortions industry-wide.
Private-label competition remains a persistent competitive pressure across cleaning and household-products categories, particularly in value-oriented retail channels.
Input costs for resin, packaging materials, and other commodities used in cleaning and household products can be volatile, directly affecting industry-wide margins.
Consumer preferences have shifted somewhat toward products marketed as more environmentally sustainable, prompting reformulation and packaging investments across the industry.
Live Key Statistics
Pulled live from BriMindInvest's market-data pipeline at page load — the same feed that powers /analysis/CLX. Fields the pipeline doesn't return this load are omitted rather than shown blank.
Business Overview
Clorox generates revenue across four segments: Health & Wellness (Clorox bleach, disinfecting wipes, cleaning products), Household (Glad trash bags, Fresh Step cat litter, Kingsford charcoal), Lifestyle (Burt's Bees, Hidden Valley dressings, Brita water filtration), and International.
Growth strategy centers on brand investment, product innovation, and pricing actions to navigate post-pandemic demand normalization, alongside operational-resilience investments following a significant cybersecurity incident.
Segment Deep Dive
A closer look at each reporting segment individually, rather than treating the business as a single undifferentiated revenue line.
Clorox's core cleaning and disinfecting products segment, which saw a significant pandemic-era demand surge followed by a normalization period as elevated demand faded.
Glad trash bags, Fresh Step cat litter, and Kingsford charcoal, a diversified set of household staples with generally stable, non-discretionary demand.
Burt's Bees personal care, Hidden Valley dressings, and Brita water-filtration products, spanning personal care, food, and water-filtration categories with differing growth profiles.
Clorox's operations outside the United States, providing geographic diversification alongside exposure to foreign-exchange fluctuations and varying category penetration levels.
Capital Allocation & Balance Sheet Philosophy
How management has historically chosen to deploy cash — buybacks, dividends, R&D, and acquisitions — and what that reveals about capital discipline.
Clorox has a long-standing track record as a reliable dividend payer, with a multi-decade history of consecutive annual dividend increases reflecting the company's stable cash-flow base.
Capital spending priorities include manufacturing efficiency and IT-infrastructure resilience investments following a significant cybersecurity incident, alongside continued brand and innovation spending.
Share buybacks have historically supplemented the dividend as part of a broader capital-return program, though the pace has been balanced against investment needs during the post-pandemic demand-normalization period.
Management & Governance
Leadership, incentive alignment, and governance structure — factors that shape execution risk independent of the underlying business model.
Clorox's leadership has focused on managing through post-pandemic demand normalization, strengthening IT-infrastructure resilience following a major cybersecurity incident, and sustaining the company's long-standing dividend track record.
Prospective investors should review the company's most recent proxy statement and 10-K for current board composition, executive compensation structure, and insider ownership details, since these are disclosed directly by the company and evolve over time rather than being estimated by third parties.
See exactly how we get CLX's fair-value range
Forecast Revenue and Free Cash Flow
5-Year Monte Carlo Simulation
Included with a subscription or a one-time purchase of this Clorox report:
- Fair value from 7 methods, weighted by relevance to this business
- 5-year financial forecast and DCF/earnings sensitivity grids
- Decomposed AI Score, Monte Carlo simulation, and institutional/analyst data
$3.99 is less than one bad options trade — see the model before you commit real money.
Bull Case vs. Bear Case
- Strong, well-known brands (Clorox, Glad, Burt's Bees, Kingsford) provide durable pricing power and shelf presence across diverse categories.
- A multi-decade dividend-growth track record signals financial stability and reliable capital returns.
- Largely non-discretionary product demand across cleaning and household categories provides resilience through economic downturns.
- Post-pandemic demand normalization is a largely known, well-understood headwind that should eventually anniversary out of year-over-year comparisons.
- Ongoing cost-savings and operational-efficiency programs support margin resilience amid input-cost volatility.
- Post-pandemic demand normalization in the Health & Wellness segment has created difficult multi-year growth comparisons and uncertainty about a sustainable underlying growth rate.
- The company's prior cybersecurity incident highlighted operational and IT-infrastructure vulnerabilities that require ongoing investment to fully remediate.
- Intensifying private-label competition pressures pricing power, particularly in the core bleach and general-cleaning categories.
- Input-cost inflation for resin and packaging materials can compress margins if pricing actions lag cost increases.
- A diversified but somewhat disparate portfolio across cleaning, food, personal care, and water filtration can complicate a single, unified growth narrative for investors.
Related Reports
In-depth reports for other names in Clorox's comparable set.
5 catalysts and 5 risks we're tracking for CLX
| Catalyst | Expected Impact | Timeframe |
|---|---|---|
Included with a subscription or a one-time purchase of this Clorox report:
- Catalyst list, each tagged with expected impact and timing
- Risk register scored by probability and severity
- 4 key metrics to watch before the next earnings report
$3.99 is less than one bad options trade — see the model before you commit real money.
What Would Change Our Mind?
Specific, falsifiable triggers — not vague sentiment — that would move us toward or away from the bull case above.
- Stabilizing or reaccelerating organic growth in the Health & Wellness segment.
- Successful pricing actions sustaining margins despite input-cost pressure.
- Full resilience-building following the prior cybersecurity incident with no recurrence.
- Continued market-share resilience against private-label competition.
- Deeper or more prolonged post-pandemic demand normalization than expected.
- Persistent private-label share gains eroding branded pricing power.
- Sustained input-cost inflation outpacing pricing and cost-savings actions.
- Additional operational or cybersecurity disruptions affecting the business.
Competitive Positioning
Procter & Gamble is Clorox's closest large-scale competitor, overlapping across several cleaning and household-products categories with comparable global brand scale.
Church & Dwight and Kimberly-Clark compete in adjacent household-products categories, offering comparison points on brand strength and pricing power within staples-like consumer categories.
Private-label and regional store-brand alternatives represent an ongoing competitive pressure, particularly in bleach and general cleaning-products categories where brand differentiation can be harder to sustain.
Clorox's brand equity in its namesake bleach franchise, built over decades and reinforced by pandemic-era disinfecting associations, remains a key competitive moat within the cleaning-products category specifically.
Investor Decision Framework
A process for using this report, not a recommendation — how to weigh valuation, scenario spread, and your own risk tolerance.
- This section is educational, not a personalized recommendation — it is a framework for organizing your own analysis, not an instruction to buy or sell CLX.
- A central judgment call for this stock is what a sustainable, normalized organic growth rate looks like for the Health & Wellness segment once pandemic-era comparisons fully cycle through.
- Consider tracking Health & Wellness organic sales trends and gross margins each quarter as the clearest signals of underlying business health.
- Weigh Clorox's dividend stability and brand strength against the uncertainty created by post-pandemic demand normalization and the prior cybersecurity incident.
- Revisit the thesis with each quarterly earnings release and any material shift in input-cost or competitive dynamics.
- Cross-check this report's live analyst rating distribution and consensus price target against your own view.
The BriMindInvest Edge
Why this report is different from asking a general-purpose AI chatbot about the stock.
- Every valuation number on this page is computed live from current market data through our own DCF, scoring, and Monte Carlo engines — not summarized or paraphrased from other analysts' reports the way a general chatbot would.
- The relevance-weighted fair value, reverse-DCF market-implied growth, fundamentals-based Monte Carlo, and scenario tables above are proprietary calculations you cannot get by asking a general-purpose AI for "CLX fair value" — those answers come from web summaries of other people's price targets, not a live, disclosed-assumption model.
- Our 1-year price-target model has a real, published backtest (see Model Track Record above where covered) — we show our work and our error rate rather than asserting accuracy.
- Numbers here are refreshed every time you load the page, not cached from a training cutoff months or years in the past.
Data Sources & Methodology
Valuation, price, and financial-statistics data in this report are fetched live from our production market-data pipeline (Yahoo Finance and Finnhub) at the time you loaded this page. The AI Score is a percentile ranking against our full covered stock universe, recomputed nightly. The fundamentals-based Monte Carlo and Bull/Base/Bear scenarios randomize growth rate, discount rate, and terminal growth around the same disclosed DCF assumptions used in the valuation table — they are not derived from resampled historical stock returns. The secondary historical-volatility simulation (2,000 bootstrap paths, seeded for reproducibility) uses the stock's own historical monthly returns and is shown separately because it measures a different thing (volatility) than the fundamentals-based model (intrinsic value).
This report is for informational and educational purposes only and does not constitute financial, investment, or tax advice, or a recommendation to buy or sell any security. All valuation models, price targets, and simulations are estimates based on historical and current data; actual results will differ, potentially substantially. Investing involves risk, including loss of principal. See our full Methodology and Disclaimer.
Free vs. Premium: What You're Getting
- Narrative overview and general bull/bear framing
- Headline price and basic company facts
- No live valuation model, AI Score, or forecast table
- Relevance-weighted fair value range and reverse-DCF market-implied growth
- 5-year financial forecast, DCF sensitivity grid, and Bull/Base/Bear scenario table
- Fundamentals-based Monte Carlo and decomposed AI Score with sub-factor components
- Real, published backtested accuracy where CLX is in our coverage set
Glossary of Key Terms
Plain-English definitions for the terms used throughout this report, for readers newer to equity valuation.
Frequently Asked Questions
Unlock Full AI-Powered Analysis
Get AI prediction signals, unlimited stock comparisons, portfolio analytics, and personalized watchlists — free for 14 days, no credit card required.
14-day free trial · No credit card required · Cancel anytime